{"filing":{"accession_number":"0001493152-26-036279","cik":"0001679628","ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226036279/form8-k.htm"},"events":[{"id":25782,"run_id":23402,"accession_number":"0001493152-26-036279","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"Jupiter Neurosciences executed a 1-for-75 reverse stock split, explicitly stated to be \"intended to increase the per share trading price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.\" This disclosure directly addresses delisting risk and the company's remedial action to avoid it, making this a material delisting-risk event.","company_name":"JUPITER NEUROSCIENCES, INC.","ticker":"JUNS","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":26701,"accession_number":"0001493152-26-036279","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"Jupiter Neurosciences executed a 1-for-75 reverse stock split, explicitly stated to be \"intended to increase the per share trading price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.\" This disclosure directly addresses delisting risk and the company's remedial action to avoid it, making this a material delisting-risk event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:33:34.452526+00:00","company_name":"JUPITER NEUROSCIENCES, INC.","ticker":"JUNS","filing_date":"2026-08-06"}]}